783 related articles for article (PubMed ID: 31293340)
1. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.
Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B
World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340
[TBL] [Abstract][Full Text] [Related]
2. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
3. Role of NLRC5 in progression and reversal of hepatic fibrosis.
Liu X; Wu Y; Yang Y; Li W; Huang C; Meng X; Li J
Toxicol Appl Pharmacol; 2016 Mar; 294():43-53. PubMed ID: 26806094
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways.
Shi L; Zhou L; Han M; Zhang Y; Zhang Y; Yuan XX; Lu HP; Wang Y; Yang XL; Liu C; Wang J; Liang P; Liu SA; Liu XJ; Cheng J; Lin SM
World J Gastroenterol; 2023 May; 29(18):2798-2817. PubMed ID: 37274069
[TBL] [Abstract][Full Text] [Related]
5. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
6. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
7. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
8. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
11. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
Wang H; Che J; Cui K; Zhuang W; Li H; Sun J; Chen J; Wang C
Phytomedicine; 2021 Jul; 88():153609. PubMed ID: 34126414
[TBL] [Abstract][Full Text] [Related]
12. A polysaccharide from Codonopsis pilosula roots attenuates carbon tetrachloride-induced liver fibrosis via modulation of TLR4/NF-κB and TGF-β1/Smad3 signaling pathway.
Meng X; Kuang H; Wang Q; Zhang H; Wang D; Kang T
Int Immunopharmacol; 2023 Jun; 119():110180. PubMed ID: 37068337
[TBL] [Abstract][Full Text] [Related]
13. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Isodon ternifolius-medicated serum on hepatic stellate cells based on TLR4/NF-κB/NLRP3 signaling pathway].
Huang GD; Zhou ZP; Pang Z; Qin L; Wu RS; Chen Y; Ye XX
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3913-3921. PubMed ID: 37475083
[TBL] [Abstract][Full Text] [Related]
15. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
17. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
18. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.
Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY
World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625
[TBL] [Abstract][Full Text] [Related]
20. Jiawei Taohe Chengqi Decoction attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src/ERK/Smad3 signal pathway.
Huang Y; Wang ZL; He Y; Ye LM; Guo WQ; Zhang JJ
J Ethnopharmacol; 2023 Apr; 305():116059. PubMed ID: 36549368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
